Klein R, Klein B E, Moss S E, Cruickshanks K J
Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison.
Arch Intern Med. 1994 Oct 10;154(19):2169-78.
The object was to examine the relationship of hyperglycemia, as measured by glycosylated hemoglobin level, to the incidence and progression of diabetic retinopathy over a 10-year period.
Patients who were younger (n = 682) and older (n = 834) than 30 years at onset of diabetes participated in baseline (1980-1982) and follow-up (1984-1986 and 1990-1992) examinations of a population-based cohort study. Glycosylated hemoglobin levels were measured by microcolumn. Retinopathy was determined from stereoscopic fundus photographs.
Persons with glycosylated hemoglobin levels in the highest quartile at baseline were more likely to have progression of retinopathy than persons with levels in the lowest quartile (younger-onset group: relative risk [RR], 2.9; 95% confidence interval [CI], 2.3 to 3.5; older-onset group taking insulin: RR, 2.1; 95% CI, 1.6 to 2.8; and older-onset group not taking insulin: RR, 4.3; 95% CI, 3.0 to 6.2) and were more likely to develop proliferative diabetic retinopathy (younger-onset group: RR, 7.1; 95% CI, 4.6 to 11.1; older-onset group taking insulin: RR, 3.1; 95% CI, 1.5 to 6.1; and older-onset group not taking insulin: RR, 13.8; 95% CI, 4.8 to 39.5). These relations were significant (P < .005) in all groups examined, even after controlling for other risk variables.
These data are compatible with the hypothesis that long-term control of hyperglycemia, as measured by glycosylated hemoglobin levels, is a significant risk factor for the long-term progression of diabetic retinopathy and that lower levels of glycosylated hemoglobin, even later in the course of diabetes, may modify the risk imposed by higher levels earlier in the course of disease in people with both younger- and older-onset diabetes.
本研究旨在通过糖化血红蛋白水平来检测高血糖与糖尿病视网膜病变在10年期间的发病率及病情进展之间的关系。
参与一项基于人群队列研究的糖尿病患者中,682名发病时年龄小于30岁,834名发病时年龄大于30岁,他们接受了基线检查(1980 - 1982年)以及随访检查(1984 - 1986年和1990 - 1992年)。糖化血红蛋白水平通过微柱法测量。视网膜病变通过立体眼底照片确定。
基线时糖化血红蛋白水平处于最高四分位数的人群比处于最低四分位数的人群更易出现视网膜病变进展(年轻发病组:相对危险度[RR],2.9;95%置信区间[CI],2.3至3.5;老年发病组使用胰岛素:RR,2.1;95% CI,1.6至2.8;老年发病组未使用胰岛素:RR,4.3;95% CI,3.0至6.2),且更易发展为增殖性糖尿病视网膜病变(年轻发病组:RR,7.1;95% CI,4.6至11.1;老年发病组使用胰岛素:RR,3.1;95% CI,1.5至6.1;老年发病组未使用胰岛素:RR,13.8;95% CI,4.8至39.5)。在所有检查的组中,即使在控制了其他风险变量后,这些关系仍具有显著性(P < 0.005)。
这些数据与以下假设相符,即通过糖化血红蛋白水平衡量的高血糖长期控制是糖尿病视网膜病变长期进展的重要危险因素,且较低的糖化血红蛋白水平,即使在糖尿病病程后期,也可能改变疾病早期较高水平所带来的风险,无论对于年轻发病还是老年发病的糖尿病患者。